| 摘要 |
Provided in the present invention are: a biomarker for predicting a heart damage and a lung damage caused by a radiation exposure; a pharmaceutical composition for predicting a heart damage and a lung damage, which detects the biomarker, and a kit comprising the composition; and a method for detecting the biomarker to provide information required to predict a heart damage and a lung damage by a radiation exposure. [Reference numerals] (AA) H&E dyeing; (BB) Blood vessel of a control group; (CC) Heart which is not irradiated with the radiation; (DD) Blood vessel irradiated with the radiation; (EE) Endothelial cell separation phenomenon; (FF) Heart after one month of irradiating 12.5 Gy |
